Nightmares in midlife may point to future cognitive decline, dementia
Jul 12, 2024
The findings were seen in middle-aged and older adults from the general population who did not have Parkinson’s disease.
Self-administered gerocognitive exam improves detection of cognitive issues in primary care
Jul 02, 2024
Detection rates appear to increase during nonacute office visits.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Timing of CSF biomarker divergence for Alzheimer’s disease, normal cognition varies
Feb 21, 2024
Estimated times of divergence of cerebrospinal fluid biomarkers vary from 18 years for Aβ42 to six years for cognitive decline.
Panel of 48 CSF proteins complements existing Alzheimer’s biomarkers
Sep 07, 2023
The CSF 48 panel plus existing biomarkers significantly improved the diagnostic performance for the outcomes studied.
Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.
Staying married in midlife tied to lower later dementia risk
Feb 14, 2023
Being divorced or single increases the risk for dementia.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Cognitive difficulties tied to lower return to work after breast cancer
Aug 23, 2024
Return to work two years after diagnosis was associated with higher cognitive speed performance before and after cancer treatment.
Cognitive impairment more often experienced by patients with RA
Jul 31, 2024
People with rheumatoid arthritis with moderate-to-high inflammation also have lower mean values in the Montreal Cognitive Assessment and lower executive function scores.